series-b
Stage
1
Investors
About
Verge Labs uses AI-driven foundation models trained on extensive multimodal brain patient data to improve drug discovery and precision neurology for neurodegenerative diseases, enabling better target identification, patient stratification, and clinical trial design.
Explore Verge Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.